T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Haverty Furniture Companies
HVT
$450M
| $32.7M | 0.01% |
1,513,070
-60,870
| -4% | -$1.33M |
|
|
CWEI
977
DELISTED
Clayton Williams Energy, Inc.
CWEI
| $32.6M | 0.01% |
496,455
+14,140
| +3% | +$801K |
|
|
OREX
978
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $32.6M | 0.01% |
658,370
-2,910
| -0.4% | -$174K |
|
|
TXTR
979
DELISTED
TEXTURA CORPORATION COM
TXTR
| $32.5M | 0.01% |
1,166,800
+1,100
| +0.1% | +$31.3K |
|
|
MDVN
980
DELISTED
MEDIVATION, INC.
MDVN
| $32.1M | 0.01% |
562,494
+262,360
| +87% | +$16.2M |
|
|
AMAG
981
DELISTED
AMAG Pharmaceuticals
AMAG
| $32.1M | 0.01% |
464,470
+27,200
| +6% | +$1.71M |
|
|
CDR
982
DELISTED
Cedar Realty Trust, Inc
CDR
| $31.8M | 0.01% |
752,827
+230,724
| +44% | +$10.6M |
|
|
GTS
983
DELISTED
Triple-S Management Corporation
GTS
| $31.8M | 0.01% |
1,302,058
-180,611
| -12% | -$3.83M |
|
|
ROIC
984
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $31.6M | 0.01% |
2,021,800
+252,520
| +14% | +$4.22M |
|
985
HEICO Corp Class A
HEI.A
$38.1B
| $31.4M | 0.01% |
1,512,280
-425,537
| -22% | -$8.51M |
|
|
BRS
986
DELISTED
Bristow Group, Inc.
BRS
| $31.4M | 0.01% |
589,130
-314,385
| -35% | -$18.4M |
|
|
LXFT
987
DELISTED
Luxoft Holding, Inc.
LXFT
| $31.1M | 0.01% |
549,587
+6,330
| +1% | +$343K |
|
988
Rockwell Automation
ROK
$49.5B
| $31M | 0.01% |
248,620
+2,800
| +1% | +$337K |
|
989
MGIC Investment
MTG
$6.33B
| $31M | 0.01% |
2,720,028
+180,138
| +7% | +$1.92M |
|
|
VVC
990
DELISTED
Vectren Corporation
VVC
| $30.9M | 0.01% |
804,229
+193,010
| +32% | +$8.14M |
|
|
BLCM
991
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $30.9M | 0.01% |
145,213
-7,610
| -5% | -$1.87M |
|
|
CUDA
992
DELISTED
Barracuda Networks, Inc.
CUDA
| $30.8M | 0.01% |
777,900
+244,820
| +46% | +$10M |
|
993
Newell Brands
NWL
$2.63B
| $30.8M | 0.01% |
749,059
+86,900
| +13% | +$3.48M |
|
|
FCS
994
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $30.8M | 0.01% |
1,770,830
-1,400
| -0.1% | -$26.8K |
|
995
Brady Corp
BRC
$4.43B
| $30.8M | 0.01% |
1,243,920
+145,110
| +13% | +$3.8M |
|
996
Consolidated Edison
ED
$40.1B
| $30.7M | 0.01% |
529,564
+25,500
| +5% | +$1.54M |
|
997
Team
TISI
$101M
| $30.6M | 0.01% |
75,906
+880
| +1% | +$352K |
|
|
CTRA
998
DELISTED
Coterra Energy
CTRA
| $30.5M | 0.01% |
967,460
-6,505
| -0.7% | -$217K |
|
|
SAGE
999
DELISTED
Sage Therapeutics
SAGE
| $30.5M | 0.01% |
417,927
+328,049
| +365% | +$21.1M |
|
1000
Applied Industrial Technologies
AIT
$13.2B
| $30.5M | 0.01% |
768,602
+1,000
| +0.1% | +$42.5K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.